litlas
Log inCreate account

Thomas F. Gajewski

Active 1988–2025

161
Papers
63,734
Citations
106
h-index
160
i10-index

Citations

Citations per year for Thomas F. Gajewski1961: 1 citations1988: 2 citations1989: 13 citations1990: 9 citations1991: 40 citations1992: 43 citations1993: 65 citations1994: 58 citations1995: 71 citations1996: 73 citations1997: 93 citations1998: 139 citations1999: 133 citations2000: 129 citations2001: 94 citations2002: 87 citations2003: 97 citations2004: 107 citations2005: 90 citations2006: 129 citations2007: 139 citations2008: 128 citations2009: 146 citations2010: 174 citations2011: 148 citations2012: 201 citations2013: 310 citations2014: 365 citations2015: 626 citations2016: 923 citations2017: 1,201 citations2018: 1,444 citations2019: 3,470 citations2020: 4,350 citations2021: 4,338 citations2022: 3,454 citations2023: 2,724 citations2024: 3,552 citations2025: 1,906 citations2026: 65 citations1962–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 9,081 citing papers, 28.4% of this breakdownChina: 6,155 citing papers, 19.3% of this breakdownGermany: 1,477 citing papers, 4.6% of this breakdownUnited Kingdom: 1,448 citing papers, 4.5% of this breakdownItaly: 1,343 citing papers, 4.2% of this breakdownFrance: 1,251 citing papers, 3.9% of this breakdownJapan: 885 citing papers, 2.8% of this breakdownCanada: 835 citing papers, 2.6% of this breakdownAustralia: 825 citing papers, 2.6% of this breakdownNetherlands: 771 citing papers, 2.4% of this breakdownSpain: 679 citing papers, 2.1% of this breakdownSwitzerland: 671 citing papers, 2.1% of this breakdown
0%28.4%Other 20.5%

Institutions

Fields

  • Medicine45.1%
  • Immunology and Microbiology24.6%
  • Biochemistry, Genetics and Molecular Biology24.4%
  • Neuroscience2%
  • Engineering1.8%
  • Agricultural and Biological Sciences0.5%
  • Other1.6%

Topics

  • Cancer Immunotherapy and Biomarkers12.8%
  • Immunotherapy and Immune Responses8.2%
  • Immune Cell Function and Interaction6.1%
  • CAR-T cell therapy research5%
  • Immune cells in cancer4.1%
  • Gut microbiota and health3.2%
  • Other60.6%

Coauthors

All papers

Open in search
  1. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

    Authors: Ayelet Sivan, Leticia Corrales, Nathaniel Hubert, Jason B. Williams, Keston Aquino-Michaels, Zachary M. Earley, Franco W. Benyamin, Yuk Man Lei, Bana Jabrì, Maria‐Luisa Alegre, Eugene B. Chang, Thomas F. Gajewski - Science 2015 cited by 3,855

  2. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

    Authors: Vyara Matson, Jessica Fessler, Riyue Bao, Tara Chongsuwat, Yuanyuan Zha, Maria‐Luisa Alegre, Jason J. Luke, Thomas F. Gajewski - Science 2018 cited by 3,072

  3. Innate and adaptive immune cells in the tumor microenvironment

    Authors: Thomas F. Gajewski, Hans Schreiber, Yang‐Xin Fu - Nature Immunology 2013 cited by 4,228

  4. Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

    Authors: Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov, Alexis Desrichard, Walter J. Urba, Jennifer S. Sims, F. Stephen Hodi, Salvador Martín‐Algarra, Rajarsi Mandal, William H. Sharfman, Shailender Bhatia, Wen-Jen Hwu, Thomas F. Gajewski, Craig L. Slingluff, Diego Chowell, Sviatoslav M. Kendall, Han Chang, Rachna Shah, Fengshen Kuo, Luc G.T. Morris, John-William Sidhom, Jonathan P. Schneck, Christine E. Horak, Nils Weinhold, Timothy A. Chan - Cell 2017 cited by 2,595

  5. STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors

    Authors: Seng‐Ryong Woo, Mercedes B. Fuertes, Leticia Corrales, Stefani Spranger, Michael J. Furdyna, Michael Y.K. Leung, Ryan Duggan, Ying Wang, Glen N. Barber, Katherine A. Fitzgerald, Maria-Luisa Alegre, Thomas F. Gajewski - Immunity 2014 cited by 1,834

  6. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors

    Authors: Liufu Deng, Hua Liang, Meng Xu, Xuanming Yang, Byron Burnette, Ainhoa Arina, Xiao-Dong Li, Helena J. Mauceri, Michael A. Beckett, Thomas E. Darga, Xiaona Huang, Thomas F. Gajewski, Zhijian J. Chen, Yang‐Xin Fu, Ralph R. Weichselbaum - Immunity 2014 cited by 2,079

  7. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

    Authors: Stefani Spranger, Riyue Bao, Thomas F. Gajewski - Nature 2015 cited by 2,840

  8. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

    Authors: Leticia Corrales, Laura Hix Glickman, Sarah M. McWhirter, David B. Kanne, Kelsey E. Sivick, George E. Katibah, Seng‐Ryong Woo, Edward E. Lemmens, Tamara Banda, Justin J. Leong, Ken Metchette, Thomas W. Dubensky, Thomas F. Gajewski - Cell Reports 2015 cited by 1,502

  9. Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy

    Authors: Stefani Spranger, Daisy Dai, Brendan Horton, Thomas F. Gajewski - Cancer Cell 2017 cited by 1,410

  10. Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Authors: Weiyi Peng, Jie Qing Chen, Chengwen Liu, Shruti Malu, Caitlin Creasy, Michael T. Tetzlaff, Chunyu Xu, Jodi A. McKenzie, Chunlei Zhang, Xiaoxuan Liang, Leila J. Williams, Wanleng Deng, Guo Chen, Rina M. Mbofung, Alexander J. Lazar, Carlos A. Torres‐Cabala, Zachary A. Cooper, Pei-Ling Chen, Trang N. Tieu, Stefani Spranger, Xiaoxing Yu, Chantale Bernatchez, Marie‐Andrée Forget, Cara Haymaker, Rodabe N. Amaria, Jennifer L. McQuade, Isabella C. Glitza, Tina Cascone, Haiyan S. Li, Lawrence N. Kwong, Timothy P. Heffernan, Jianhua Hu, Roland L. Bassett, Marcus Bosenberg, Scott E. Woodman, Willem W. Overwijk, Gregory Lizée, Jason Roszik, Thomas F. Gajewski, Jennifer A. Wargo, Jeffrey E. Gershenwald, Laszlo Radvanyi, Michael A. Davies, Patrick Hwu - Cancer Discovery 2015 cited by 1,531

  11. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

    Authors: Georgina V. Long, Reinhard Dummer, Omid Hamid, Thomas F. Gajewski, Christian Caglevic, Stéphane Dalle, Ana Arance, Matteo S. Carlino, Jean‐Jacques Grob, Tae Min Kim, Lev Demidov, Caroline Robert, James Larkin, James R. Anderson, Janet Maleski, Mark M. Jones, Scott J. Diede, Tara C. Mitchell - The Lancet Oncology 2019 cited by 944

  12. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

    Authors: Antoni Ribas, Reinhard Dummer, Igor Puzanov, Ari M. Vanderwalde, Robert H.I. Andtbacka, Olivier Michielin, Anthony J. Olszanski, Josep Malvehy, Jonathan Cebon, Eugenio Fernández, John M. Kirkwood, Thomas F. Gajewski, Lisa Chen, Kevin Gorski, Abraham Anderson, Scott J. Diede, Michael E. Lassman, Jennifer Gansert, F. Stephen Hodi, Georgina V. Long - Cell 2017 cited by 1,506

  13. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

    Authors: Mercedes B. Fuertes, Aalok Kacha, Justin Kline, Seng‐Ryong Woo, David M. Kranz, Kenneth M. Murphy, Thomas F. Gajewski - The Journal of Experimental Medicine 2011 cited by 1,179

  14. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies

    Authors: Laurence Zitvogel, Yuting Ma, Didier Raoult, Guido Kroemer, Thomas F. Gajewski - Science 2018 cited by 780

  15. Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells

    Authors: Stefani Spranger, Robbert M. Spaapen, Yuanyuan Zha, Jason B. Williams, Yuru Meng, Thanh T. Ha, Thomas F. Gajewski - Science Translational Medicine 2013 cited by 1,674

  16. Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy

    Authors: Vyara Matson, Carolina Soto Chervin, Thomas F. Gajewski - Gastroenterology 2020 cited by 376

  17. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

    Authors: Jason J. Luke, Riyue Bao, Randy F. Sweis, Stefani Spranger, Thomas F. Gajewski - Clinical Cancer Research 2019 cited by 692

  18. Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

    Authors: Jason Chesney, Antoni Ribas, Georgina V. Long, John M. Kirkwood, Reinhard Dummer, Igor Puzanov, Christoph Höeller, Thomas F. Gajewski, Ralf Gutzmer, Piotr Rutkowski, Lev Demidov, Petr Arenberger, Sang Joon Shin, Pier Francesco Ferrucci, Andrew Haydon, John Hyngstrom, Johannes V. van Thienen, Sebastian Haferkamp, Josep Malvehy, Bernardo L. Rapoport, Ari M. Vanderwalde, Scott J. Diede, James R. Anderson, Sheryl Treichel, Edward L. Chan, Sumita Bhatta, Jennifer Gansert, F. Stephen Hodi, Helen Gogas - Journal of Clinical Oncology 2022 cited by 284

  19. Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

    Authors: Helena Harlin, Yuru Meng, Amy Peterson, Yuanyuan Zha, Maria Tretiakova, Craig L. Slingluff, Mark D. McKee, Thomas F. Gajewski - Cancer Research 2009 cited by 1,126

  20. CXCL9 and CXCL10 bring the heat to tumors

    Authors: Robin Reschke, Thomas F. Gajewski - Science Immunology 2022 cited by 240

  21. STING pathway agonism as a cancer therapeutic

    Authors: Blake Flood, Emily F. Higgs, Shuyin Li, Jason J. Luke, Thomas F. Gajewski - Immunological Reviews 2019 cited by 337

  22. Impact of oncogenic pathways on evasion of antitumour immune responses

    Authors: Stefani Spranger, Thomas F. Gajewski - Nature reviews. Cancer 2018 cited by 658

  23. Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma

    Authors: Daniel J. Olson, Zeynep Eroglu, Bruce Brockstein, Andrew Poklepovic, Madhuri Bajaj, Sunil Babu, Sigrun Hallmeyer, Mario R. Velasco, Jose Lutzky, Emily F. Higgs, Riyue Bao, Timothy Carll, Brian Labadie, Thomas Krausz, Yuanyuan Zha, Theodore Karrison, Vernon K. Sondak, Thomas F. Gajewski, Nikhil I. Khushalani, Jason J. Luke - Journal of Clinical Oncology 2021 cited by 220

  24. Brain Tumor Microenvironment and Host State: Implications for Immunotherapy

    Authors: William H. Tomaszewski, Luis Sánchez-Pérez, Thomas F. Gajewski, John H. Sampson - Clinical Cancer Research 2019 cited by 324